Abbott Laboratories buy Citigroup Inc.
Start price
25.01.24
/
50%
€102.48
Target price
25.01.25
€116.25
Performance (%)
-2.38%
Price
21:19
€99.52
Summary
This prediction is currently active. With a performance of -2.38%, the BUY prediction for Abbott Laboratories by Citigroup_Inc_ is down slightly. A total of €0.52 was paid as dividends for this prediction. This prediction currently runs until 25.01.25. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -0.218% | -0.218% |
| iShares Core DAX® | 2.594% | -1.861% |
| iShares Nasdaq 100 | 3.553% | -2.064% |
| iShares Nikkei 225® | 0.687% | -8.704% |
| iShares S&P 500 | 2.209% | -1.988% |
Comments by Citigroup_Inc_ for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Citigroup Inc. from $123.00 to $126.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€103.10
03.04.24
03.04.24
€118.21
03.04.25
03.04.25
-2.57%
21:19
21:19
